Managing and monitoring ATTR-CM: from clinical trial to real-world practice

20 May 2024 (13:20 - 13:35)

Organised by:

About the speaker

Doctor Fernando Dominguez

Hospital Universitario Puerta De Hierro Majadahonda, Madrid (Spain)

3 More presentations in this session

Presentation thumbnail

Suspecting the unexpected: transthyretin amyloid cardiomyopathy (ATTR-CM)

Doctor F. Dominguez (Madrid, ES)

Presentation thumbnail

SuSPECT ATTR-CM? Sharing clinical cases of non-invasive diagnosis using SPECT

Professor J. Vallejo (Cordoba, ES)

Presentation thumbnail

Sharing experience and insights in ATTR-CM: discussion and Q&A

Doctor F. Dominguez (Madrid, ES) Professor J. Vallejo (Cordoba, ES)

Access the full session

Session thumbnail

Cardiac scintigraphy: illuminating diagnosis of ATTR-CM with non-invasive tools

The Event

Event poster

International Conference on Nuclear Cardiology and Cardiac CT 2024

20 May 2024 13:20 CET

You may be interested in

Congress Session

ATTRibutes of change: advances in treating and monitoring ATTR-CM

17 May 2025

Congress Presentation

Remote monitoring in cardiac transthyretin amyloidosis (ATTR-CM); a digital patient centred heart failure intervention during the COVID-19 pandemic.

22 May 2023

Congress Session

Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond

20 May 2025

Congress Presentation

Monitoring patisiran and inotersen treatment with quantitative SPECT/CT in hereditary transthyretin amyloid cardiomyopathy

25 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources